Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Innovative Approach in the Cryogenic Freezing Medium for Mesenchymal Stem Cells

N. Pilbauerova, J. Schmidt, T. Soukup, T. Prat, K. Nesporova, V. Velebny, J. Suchanek

. 2022 ; 12 (5) : . [pub] 20220420

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

The physical stresses during cryopreservation affect stem cell survival and further proliferation. To minimize or prevent cryoinjury, cryoprotective agents (CPAs) are indispensable. Despite the widespread use of 10% dimethyl sulfoxide (DMSO), there are concerns about its potential adverse effects. To bypass those effects, combinations of CPAs have been investigated. This study aimed to verify whether high-molecular-hyaluronic acid (HMW-HA) serves as a cryoprotectant when preserving human mesenchymal stem cells (hMSCs) to reduce the DMSO concentration in the cryopreservation medium. We studied how 0.1% or 0.2% HMW-HA combined with reduced DMSO concentrations (from 10% to 5%, and 3%) affected total cell count, viability, immunophenotype, and differentiation potential post-cryopreservation. Immediately after cell revival, the highest total cell count was observed in 10% DMSO-stored hMSC. However, two weeks after cell cultivation an increased cell count was seen in the HMW-HA-stored groups along with a continued increase in hMSCs stored using 3% DMSO and 0.1% HMW-HA. The increased total cell count corresponded to elevated expression of stemness marker CD49f. The HA-supplemented cryomedium did not affect the differential potential of hMSC. Our results will participate in producing a ready-to-use product for cryopreservation of mesenchymal stem cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018741
003      
CZ-PrNML
005      
20220804135049.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom12050610 $2 doi
035    __
$a (PubMed)35625538
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pilbauerova, Nela $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000306894546 $7 xx0214576
245    10
$a Innovative Approach in the Cryogenic Freezing Medium for Mesenchymal Stem Cells / $c N. Pilbauerova, J. Schmidt, T. Soukup, T. Prat, K. Nesporova, V. Velebny, J. Suchanek
520    9_
$a The physical stresses during cryopreservation affect stem cell survival and further proliferation. To minimize or prevent cryoinjury, cryoprotective agents (CPAs) are indispensable. Despite the widespread use of 10% dimethyl sulfoxide (DMSO), there are concerns about its potential adverse effects. To bypass those effects, combinations of CPAs have been investigated. This study aimed to verify whether high-molecular-hyaluronic acid (HMW-HA) serves as a cryoprotectant when preserving human mesenchymal stem cells (hMSCs) to reduce the DMSO concentration in the cryopreservation medium. We studied how 0.1% or 0.2% HMW-HA combined with reduced DMSO concentrations (from 10% to 5%, and 3%) affected total cell count, viability, immunophenotype, and differentiation potential post-cryopreservation. Immediately after cell revival, the highest total cell count was observed in 10% DMSO-stored hMSC. However, two weeks after cell cultivation an increased cell count was seen in the HMW-HA-stored groups along with a continued increase in hMSCs stored using 3% DMSO and 0.1% HMW-HA. The increased total cell count corresponded to elevated expression of stemness marker CD49f. The HA-supplemented cryomedium did not affect the differential potential of hMSC. Our results will participate in producing a ready-to-use product for cryopreservation of mesenchymal stem cells.
650    _2
$a kryoprezervace $x metody $7 D015925
650    _2
$a kryoprotektivní látky $x farmakologie $7 D003451
650    _2
$a kultivační média $7 D003470
650    12
$a dimethylsulfoxid $x farmakologie $7 D004121
650    _2
$a zmrazování $7 D005615
650    _2
$a lidé $7 D006801
650    12
$a mezenchymální kmenové buňky $7 D059630
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Schmidt, Jan $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000283997111
700    1_
$a Soukup, Tomas $u Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50003 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000174755711 $7 xx0036274
700    1_
$a Prat, Tomas $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic $1 https://orcid.org/0000000181293383
700    1_
$a Nesporova, Kristina $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic $1 https://orcid.org/0000000178647689
700    1_
$a Velebny, Vladimir $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic
700    1_
$a Suchanek, Jakub $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000238473802 $7 xx0143207
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 12, č. 5 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35625538 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135043 $b ABA008
999    __
$a ok $b bmc $g 1822384 $s 1169984
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 5 $e 20220420 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...